STOCK TITAN

American Battery Materials: $6.09M nine-month loss

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

American Battery Materials, Inc. (BLTH) reported a $6,092,170 net loss for the nine months ended September 30, 2026, versus $4,283,772 a year earlier; revenue was $0. Operating expenses were $1,745,150, interest expense was $729,157, and the company used $651,285 in operating cash. At September 30, cash was $1,465 against $13,409,310 in current liabilities, and the working-capital deficit was $13,307,845.

The company said it has no mineral reserves and has generated no mining revenue. It disclosed substantial doubt about its ability to continue as a going concern, citing its losses and dependence on additional financing to fund operations for the next 12 months. Disclosure controls and procedures were not effective due to material weaknesses. Under amendments dated October 13, 2026, if BLTH has not completed an uplisting to NYSE American by November 30, 2026, principal will automatically increase by 15% of balances outstanding June 30, or $1,489,217, and 779,901 shares will be issued to noteholders; that share total includes 612,476 issuable under the August 25 amendments.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointQuarterly net loss narrowed to $901,128 from $1,765,688 a year earlier.

Negative

  • Major point$13,307,845 working-capital deficit accompanied substantial doubt about going concern.
  • Major pointDisclosure controls and procedures were not effective due to material weaknesses.
  • Moderate pointNine-month net loss rose to $6,092,170 from $4,283,772 in 2025.
  • Moderate point. Forward-looking: it has not happened yet and may not happen.No uplist by November 30, 2026 triggers $1,489,217 debt increase and 779,901 shares. 11% of market cap

Filing Explained

Sixty thousand consultant shares are already issued; the 400,000 RSUs and the quarter’s convertible notes involve further shares only through their stated conditions.

As of November 12, 2026, American Battery Materials reported 3,849,585 common shares outstanding, after issuing 60,000 shares to a consultant for services on October 20, 2026. The issued shares increase the share count; absent offsetting changes, additional shares reduce existing holders’ percentage ownership.

After a July 29, 2026 amendment, all 400,000 restricted stock units are contingent on completion of an uplisting; no shares were issued at grant, and the units carry no voting or dividend rights before settlement. Each unit represents the right to receive one common share upon vesting and settlement, so this is a contingent potential share issuance, not completed issuance.

During the quarter, the company issued three convertible notes with aggregate principal of $325,000; each bears 10% interest. They convert automatically on an uplisting at 65%–75% of the uplisting price, depending on timing; beginning six months after issuance, holders may convert at 65% of the 20-trading-day VWAP, subject to a 4.99% beneficial ownership limit and price-protection adjustments. The $325,000 is debt principal, not shares already issued; any shares depend on an uplisting or a holder’s later conversion under the disclosed terms.

Nine-month net loss $6,092,170 Nine months ended September 30, 2026; $4,283,772 in the comparable 2025 period
Revenue $0 Nine months ended September 30, 2026 and 2025
Quarterly net loss $901,128 Three months ended September 30, 2026; $1,765,688 in the comparable 2025 period
Cash used in operating activities $651,285 Nine months ended September 30, 2026
Cash $1,465 As of September 30, 2026
Working-capital deficit $13,307,845 As of September 30, 2026
Conditional principal increase $1,489,217 Would apply if the company had not completed an uplisting by November 30, 2026
Conditional shares issued to noteholders 779,901 shares Would be issued if the company had not completed an uplisting by November 30, 2026
going concern financial
"substantial doubt as to the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
working capital deficit financial
"a working capital deficit of $13,307,845 as of September 30, 2026"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
convertible notes financial
"The Company issues convertible notes as part of its financing strategy"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
20-trading-day VWAP financial
"convert at 65% of the 20-trading-day VWAP"
beneficial ownership limit regulatory
"Conversion is subject to a 4.99% beneficial ownership limit"
A beneficial ownership limit is a cap on how much of a company's stock one person or entity can effectively control, counting both shares they hold directly and those they control indirectly. It matters to investors because the limit shapes who can gain controlling influence, can force sales or extra disclosures if crossed, and affects takeover chances and market liquidity—like a rule that prevents any single neighbor from owning most of the houses on a block.
anti-dilutive financial
"excluded ... because their inclusion would have been anti-dilutive"
A claim, security feature, or action described as anti-dilutive prevents or does not cause a reduction in existing shareholders’ per-share values when additional shares could be issued. For example, certain convertible securities or corporate actions are treated as anti-dilutive for earnings-per-share calculations if including them would raise EPS rather than lower it; investors watch this because it affects reported per-share metrics, ownership percentages, and valuation comparisons, like keeping pie slices the same size instead of making them smaller.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were BLTH's revenue and net loss for the first nine months of 2026?

BLTH reported $0 revenue and a $6,092,170 net loss for the nine months ended September 30, 2026. The net loss was $4,283,772 for the same period in 2025.

What are the conversion terms on BLTH's 2026 convertible notes?

The three notes issued in July, August and September 2026 bear 10% simple interest. They convert automatically upon an uplisting at 65%-75% of the uplist price, depending on timing. Beginning six months after issuance, holders may convert at 65% of the 20-trading-day VWAP, subject to a 4.99% beneficial ownership limit and price-protection adjustments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0001487718 0001487718 2026-01-01 2026-09-30 0001487718 2026-11-12 0001487718 2026-09-30 0001487718 2025-12-31 0001487718 2026-07-01 2026-09-30 0001487718 2025-07-01 2025-09-30 0001487718 2025-01-01 2025-09-30 0001487718 us-gaap:PreferredStockMember 2024-12-31 0001487718 us-gaap:CommonStockMember 2024-12-31 0001487718 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001487718 BLTH:StockToBeIssuedMember 2024-12-31 0001487718 us-gaap:RetainedEarningsMember 2024-12-31 0001487718 2024-12-31 0001487718 us-gaap:PreferredStockMember 2025-12-31 0001487718 us-gaap:CommonStockMember 2025-12-31 0001487718 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001487718 BLTH:StockToBeIssuedMember 2025-12-31 0001487718 us-gaap:RetainedEarningsMember 2025-12-31 0001487718 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001487718 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001487718 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001487718 BLTH:StockToBeIssuedMember 2025-01-01 2025-09-30 0001487718 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001487718 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001487718 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487718 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001487718 BLTH:StockToBeIssuedMember 2026-01-01 2026-09-30 0001487718 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001487718 us-gaap:PreferredStockMember 2025-09-30 0001487718 us-gaap:CommonStockMember 2025-09-30 0001487718 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001487718 BLTH:StockToBeIssuedMember 2025-09-30 0001487718 us-gaap:RetainedEarningsMember 2025-09-30 0001487718 2025-09-30 0001487718 us-gaap:PreferredStockMember 2026-09-30 0001487718 us-gaap:CommonStockMember 2026-09-30 0001487718 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001487718 BLTH:StockToBeIssuedMember 2026-09-30 0001487718 us-gaap:RetainedEarningsMember 2026-09-30 0001487718 2021-11-05 2021-11-05 0001487718 BLTH:SageMineralsLLCMember 2023-04-25 0001487718 2023-12-08 2023-12-08 0001487718 2025-01-24 2025-01-24 0001487718 2025-01-23 0001487718 2025-01-24 0001487718 srt:MinimumMember 2026-09-30 0001487718 srt:MaximumMember 2026-09-30 0001487718 us-gaap:ConvertibleDebtMember 2026-01-01 2026-09-30 0001487718 us-gaap:ConvertibleDebtMember 2025-01-01 2025-09-30 0001487718 BLTH:OnePromissoryNoteAgreementMember 2025-01-01 2025-12-31 0001487718 BLTH:OnePromissoryNoteAgreementMember 2026-01-01 2026-09-30 0001487718 BLTH:OnePromissoryNoteAgreementMember 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementMember 2025-01-01 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementMember 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementMember us-gaap:RelatedPartyMember 2026-01-01 0001487718 BLTH:PromissoryNoteAgreementMember 2026-01-01 2026-03-31 0001487718 BLTH:PromissoryNoteAgreementMember 2026-06-30 2026-06-30 0001487718 BLTH:PromissoryNoteAgreementMember 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementMember BLTH:PromissoryNotesMember 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementMember BLTH:TwoConvertibleNotesMember 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementMember 2026-09-04 0001487718 BLTH:PromissoryNoteAgreementMember 2026-01-01 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember 2026-01-31 2026-01-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:CommonStockMember 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementOneMember 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementOneMember 2026-01-01 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember 2025-01-01 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2025-01-01 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2025-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2025-10-31 2025-10-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember 2025-10-31 2025-10-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:PromissoryNoteAgreementOneMember us-gaap:RelatedPartyMember 2026-09-30 0001487718 BLTH:FourPromissoryNoteAgreementsMember 2025-12-31 0001487718 BLTH:FourPromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:FourPromissoryNoteAgreementsMember 2025-01-01 2025-12-31 0001487718 BLTH:FourPromissoryNoteAgreementsMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember 2025-01-01 2025-12-31 0001487718 BLTH:FourPromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:FourPromissoryNoteAgreementsMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:FourPromissoryNoteAgreementsMember 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember srt:MinimumMember 2026-01-01 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember srt:MaximumMember 2026-01-01 2026-09-30 0001487718 BLTH:TenPromissoryNoteAgreementsMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:AnotherHolderNoteAgreementsMember 2026-09-30 0001487718 BLTH:AnotherHolderNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:ConvertibleNotesMember 2025-01-01 2025-12-31 0001487718 us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:TriggeringTransactionIfWithinOneTwentyDaysMember 2025-01-01 2025-12-31 0001487718 BLTH:TriggeringTransactionIfWithinOneTwentyOneToOneFiftyDaysMember 2025-01-01 2025-12-31 0001487718 BLTH:TriggeringTransactionIfMoreThanOneFiftydaysMember 2025-01-01 2025-12-31 0001487718 BLTH:SixInvestorsMember srt:MinimumMember 2024-12-31 0001487718 BLTH:SixInvestorsMember srt:MaximumMember 2024-12-31 0001487718 BLTH:SixInvestorsMember srt:MinimumMember 2024-01-01 2024-12-31 0001487718 BLTH:SixInvestorsMember srt:MaximumMember 2024-01-01 2024-12-31 0001487718 BLTH:SixInvestorsMember 2025-12-31 0001487718 BLTH:SixInvestorsMember 2026-03-31 0001487718 BLTH:SixInvestorsMember 2026-09-30 0001487718 BLTH:SixInvestorsMember 2026-01-01 2026-09-30 0001487718 BLTH:SixInvestorsMember 2025-01-01 2025-12-31 0001487718 srt:MinimumMember BLTH:OnePurchaserMember 2024-12-31 0001487718 srt:MaximumMember BLTH:OnePurchaserMember 2024-12-31 0001487718 srt:MinimumMember BLTH:OnePurchaserMember 2024-01-01 2024-12-31 0001487718 srt:MaximumMember BLTH:OnePurchaserMember 2024-01-01 2024-12-31 0001487718 BLTH:OnePurchaserMember 2024-10-23 2024-10-23 0001487718 BLTH:OnePurchaserMember us-gaap:CommonStockMember 2024-10-23 2024-10-23 0001487718 BLTH:OnePurchaserMember 2025-12-31 0001487718 BLTH:OnePurchaserMember 2026-09-30 0001487718 BLTH:OnePurchaserMember 2026-01-01 2026-09-30 0001487718 BLTH:OnePurchaserMember 2026-09-30 0001487718 BLTH:OnePurchaserMember 2025-01-01 2025-12-31 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember 2024-12-31 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2024-12-31 0001487718 BLTH:MostFavoredNationsMember 2024-12-31 0001487718 BLTH:MostFavoredNationsMember us-gaap:RelatedPartyMember 2024-12-31 0001487718 BLTH:MostFavoredNationsMember 2025-12-31 0001487718 BLTH:MostFavoredNationsMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2025-12-31 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember 2025-12-31 0001487718 BLTH:MostFavoredNationsMember 2026-09-30 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember 2025-01-01 2025-12-31 0001487718 BLTH:TenConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-09-30 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember 2025-12-31 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember 2025-01-01 2025-12-31 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-01-01 2025-12-31 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2025-12-31 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:FiveConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2026-09-30 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember 2025-12-31 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember 2025-07-31 2025-07-31 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-07-31 2025-07-31 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2025-12-31 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2026-09-30 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember 2026-09-30 0001487718 BLTH:SevenConvertiblePromissoryNoteAgreementsMember 2025-01-01 2025-12-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember 2025-12-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-12-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember 2025-10-31 2025-10-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2025-10-31 2025-10-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2025-12-31 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember 2026-01-01 2026-09-30 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember us-gaap:CommonStockMember 2026-09-30 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember 2026-09-30 0001487718 BLTH:SevenShortTermConvertiblePromissoryNoteAgreementsMember 2025-01-01 2025-12-31 0001487718 BLTH:OneNoteholderMember 2026-01-01 0001487718 BLTH:FourAnotherHoldersMember 2026-01-01 0001487718 BLTH:ConvertibleNoteOneMember 2026-01-01 0001487718 BLTH:ConvertibleNoteTwoMember 2026-01-01 0001487718 BLTH:ConvertibleNoteThreeMember 2026-01-01 0001487718 BLTH:ConvertibleNoteFourMember 2026-01-01 0001487718 BLTH:ConvertibleNoteFiveMember 2026-01-01 0001487718 BLTH:FourAnotherHoldersMember 2026-01-01 2026-09-30 0001487718 BLTH:FourAnotherHoldersMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487718 BLTH:FourAnotherHoldersMember 2026-09-30 0001487718 BLTH:NoteholderMember 2026-06-30 0001487718 BLTH:ConvertibleNoteOneMember 2026-06-30 0001487718 BLTH:ConvertibleNoteTwoMember 2026-06-30 0001487718 BLTH:NoteholderMember 2026-01-01 2026-09-30 0001487718 BLTH:NoteholderMember 2026-09-30 0001487718 BLTH:ThreeInvestorsMember 2026-09-30 0001487718 BLTH:ThreeInvestorsMember 2026-07-13 0001487718 BLTH:ThreeInvestorsMember 2026-08-28 0001487718 BLTH:ThreeInvestorsMember 2026-09-24 0001487718 BLTH:ThreeInvestorsMember 2026-07-01 2026-09-30 0001487718 2026-08-25 2026-08-25 0001487718 2026-08-25 0001487718 2024-08-13 0001487718 2025-10-15 2025-10-15 0001487718 srt:MinimumMember 2026-01-01 2026-09-30 0001487718 srt:MaximumMember 2026-01-01 2026-09-30 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember 2026-05-21 2026-05-21 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember 2026-05-21 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember BLTH:TimeVestingRestrictedStockUnitsMember 2026-07-01 2026-09-30 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember BLTH:TimeVestingRestrictedStockUnitsMember 2026-01-01 2026-09-30 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember BLTH:TimeVestingRestrictedStockUnitsMember 2026-09-30 0001487718 us-gaap:RestrictedStockUnitsRSUMember BLTH:CobradorCapitalAdvisorsLLCMember 2026-07-29 2026-07-29 0001487718 2025-01-01 2025-12-31 0001487718 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487718 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001487718 BLTH:SingleReportableSegmentMember 2026-01-01 2026-09-30 0001487718 us-gaap:SubsequentEventMember 2026-11-30 2026-11-30 0001487718 us-gaap:SubsequentEventMember 2026-11-30 0001487718 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-11-30 0001487718 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-10-20 2026-10-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:acre BLTH:Segments

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41594

 

AMERICAN BATTERY MATERIALS INC.

(Exact name of Registrant as specified in its charter)

 

Delaware   22-3956444

(State or Other Jurisdiction of

Incorporation or Organization)

 

(IRS Employer

Identification No.)

     
500 West Putnam Avenue, Suite 400, Greenwich, CT   06830
(Address of principal executive offices)   (Zip Code)

 

800-998-7962

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   BLTH   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares of registrant’s common stock outstanding as of November 12, 2026: 3,849,585.

 

 

 

 
 

 

AMERICAN BATTERY MATERIALS INC.

FORM 10-Q

For the quarter ended September 30, 2026

 

INDEX

 

  Page
PART I – FINANCIAL INFORMATION 1
   
Item 1. Financial Statements
  Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025 (Unaudited) 1
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited) 2
  Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the nine months ended September 30, 2026 and 2025 (Unaudited) 3
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited) 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
Item 3. Quantitative and Qualitative Disclosures About Market Risk 17
Item 4. Controls and Procedures 17
     
PART II – OTHER INFORMATION 18
     
Item 1. Legal Proceedings 18
Item 1A. Risk Factors 18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18
Item 3. Defaults Upon Senior Securities 18
Item 4. Mine Safety Disclosures 18
Item 5. Other Information 18
Item 6. Exhibits 18
  SIGNATURES 19

 

i
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

AMERICAN BATTERY MATERIALS INC.

Condensed Consolidated Balance Sheets

(Unaudited)

 

  

September 30,
2026

  

December 31,
2025

 
Assets          
Current assets          
Cash  $1,465   $3,480 
Prepaid expenses and other assets   100,000    186,885 
Total current assets   101,465    190,365 
Noncurrent assets          
Mineral claims   206,000    206,000 
Total assets  $307,465   $396,365 
Liabilities and Stockholders’ Deficit          
Current Liabilities:          
Accounts payable  $318,565   $293,029 
Accrued expenses   1,403,894    1,070,492 
Accrued interest   1,733,738    1,016,424 
Promissory notes payable   1,046,531    322,472 
Promissory notes payable – related party   

690,991

    1,043,103 
Convertible notes payable   6,708,583    5,607,630 
Convertible notes payable – related party   1,507,008    1,339,563 
Total current liabilities   13,409,310    10,692,713 
Total Liabilities   13,409,310    10,692,713 
Stockholders’ deficit          
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding   -    - 
Common stock, $0.001 par value, 100,000,000 shares authorized, 3,789,585 and 3,142,371 shares issued and outstanding, respectively   3,789    3,142 
Additional paid in capital   23,943,657    20,657,631 
Accumulated deficit   (37,049,291)   (30,957,121)
Total stockholders’ deficit   (13,101,845)   (10,296,348)
Total liabilities and stockholders’ deficit  $307,465   $396,365 

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

1

 

 

AMERICAN BATTERY MATERIALS INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

  

Three Months

Ended

September 30,

2026

  

Three Months

Ended

September 30,

2025

  

Nine Months

Ended

September 30,

2026

  

Nine Months

Ended

September 30,

2025

 
Operating Expenses                    
General and administrative  $647,249   $293,140   $1,745,150   $1,509,194 
Total operating expenses   647,249    293,140    1,745,150    1,509,194 
Operating loss   (647,249)   (293,140)   (1,745,150)   (1,509,194)
Other Expenses / Income                    
Gain (loss) on extinguishment of debt   -    (424,656)   (1,045,346)   (990,109)
Fair value of stock issued for note modification   -    (863,651)   (2,572,517)   (1,273,659)
Interest expense   (253,879)   (184,241)   (729,157)   (510,810)
Total other expenses / income   (253,879)   (1,472,548)   (4,347,020)   (2,774,578)
Loss before income taxes   (901,128)   (1,765,688)   (6,092,170)   (4,283,772)
Provision for income taxes   -    -    -    - 
Net Income (Loss)  $(901,128)  $(1,765,688)  $(6,092,170)  $(4,283,772)
Net loss per share – basic and diluted  $(0.24)  $(0.63)  $(1.65)  $(1.59)
Weighted average common shares – basic and diluted   3,789,585    2,813,583    3,695,605    2,699,784 

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

2

 

 

AMERICAN BATTERY MATERIALS INC.

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

Nine months ended September 30, 2026 and 2025

(Unaudited)

 

   Shares   Amount   Shares   Amount  

Capital

  

Issued

   Deficit  

Equity/(Deficit)

 
         Additional   Stock       Total 
   Preferred stock   Common stock   Paid in   to be   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount  

Capital

  

Issued

   Deficit  

Equity/(Deficit)

 
Balance as of December 31, 2024   -   $-    2,586,982   $2,586   $17,737,406   $-   $(24,546,557)  $(6,806,565)
Shares issued for services   -    -    73,118    74    550,341    45,000    -    595,415 
Shares issued for note modification   -    -    265,340    266    1,273,393    -    -    1,273,659 
Share-based compensation   -    -    -    -    189,766    -    -    189,766 
Net loss   -    -    -    -    -    -    (4,283,772)   (4,283,772)
Balance as of September 30, 2025   -   $-    2,925,440   $2,926   $19,750,906   $45,000   $(28,830,329)  $(9,031,497)
                                         
Balance as of December 31, 2025   -   $-    3,142,371   $3,142   $20,657,631   $-   $(30,957,121)  $(10,296,348)
Shares issued for services   -    -    70,135    70    379,162    -    -    379,232 
Shares issued for note modification   -    -    542,066    542    2,571,975    -    -    2,572,517 
Shares issued for options exercise   -    -    35,013    35    54,235    -    -    54,270 
Share-based compensation   -    -    -    -    280,654    -    -    280,654 
Net loss   -    -    -    -    -    -    (6,092,170)   (6,092,170)
Balance as of September 30, 2026   -   $-    3,789,585   $3,789   $23,943,657   $-   $(37,049,291)  $(13,101,845)

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

3

 

 

AMERICAN BATTERY MATERIALS INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

  

Nine Months

Ended

September 30,

2026

  

Nine Months

Ended

September 30,

2025

 
Cash Flows from Operating Activities          
Net income (loss)  $(6,092,170)  $(4,283,772)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock based compensation   659,886    785,181 
Accrued interest   717,314    494,766 
Gain (loss) on extinguishment of debt   1,045,346    990,109 
Fair value of stock issued for note modification   2,572,517    1,273,659 
Changes in operating assets and liabilities:          
Prepaid expenses and other assets   86,885    (157,812)
Accounts payable and accrued expenses   358,937    414,413 
Net cash used in operating activities   (651,285)   (483,456)
Cash Flows from Investing Activities:          
Net cash provided by (used in) investing activities   -    - 
Cash Flows from Financing Activities          
Proceeds from convertible notes   325,000    345,000 
Proceeds from convertible notes – related party   -    135,000 
Proceeds from promissory notes   225,000    - 
Proceeds from promissory notes – related party   45,000    - 
Proceeds from options exercise   54,270    - 
Net cash provided by financing activities   649,270    480,000 
Net decrease in cash   (2,015)   (3,456)
Cash, beginning of period   3,480    12,896 
Cash, end of period  $1,465   $9,440 
Promissory notes issued with no cash proceeds  $856,354   $- 
Common stock issued for note modification  $2,572,517   $1,273,659 

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

4

 

 

AMERICAN BATTERY MATERIALS INC.

Notes to Condensed Consolidated Financial Statements

For the Nine Months Ended September 30, 2026 and 2025 (Unaudited)

 

Note 1 - Nature of the Business

 

American Battery Materials Inc. (the “Company”) is a US based renewable energy company focused on the extraction, refinement and distribution of technical minerals in an environmentally responsible manner. On November 5, 2021, the Company acquired the rights to 102 federal mining claims located in the Lisbon Valley of Utah for $100,000, plus the future payment of royalties based on a percentage of the net revenue (2%) from the sale of all minerals produced from this portion of the mining property. The acquisition was driven by historical mineral data from seven (7) existing wells with brine aquifer access. The independent third-party Technical Report indicated that further investment and development in the claims were warranted.

 

On April 25, 2023, the Company formed Mountain Sage Minerals, LLC, a Utah limited liability company, of which it is the 100% owner. The Company will look to expand its holdings in the Lisbon Valley area with the acquisition of additional mineral claims and joint venture opportunities through this new LLC.

 

On December 8, 2023 and January 24, 2025, the Company effected reverse stock splits of its common stock at ratios of one-for-300 (the “2023 Reverse Split”) and one-for-five (the “2025 Reverse Split”), respectively. In connection with the 2025 Reverse Split, the number of authorized shares of common stock was reduced from 4,500,000,000 to 100,000,000, with no change to the $0.001 par value or to the 10,000,000 authorized shares of preferred stock. All share and per-share amounts in the condensed consolidated financial statements and related notes reflect both reverse splits.

 

The Company’s strategy is to employ selective brine extraction technologies that recover targeted minerals and metals from the brine and re-inject the brine into the aquifer, and the Company continues to evaluate extraction technology providers.

 

Note 2 - Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis. The Company had a net loss of $6,092,170 during the nine months ended September 30, 2026, has accumulated losses totaling $37,049,291, and has a working capital deficit of $13,307,845 as of September 30, 2026. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Until the Company can generate significant cash from operations, its ability to continue as a going concern is dependent upon obtaining additional financing. The Company hopes to raise additional financing, potentially through the sale of debt or equity instruments, or a combination, to fund its operations for the next 12 months and allow the Company to continue the development of its business plans and satisfy its obligations on a timely basis. Should additional financing not be available, the Company will have to negotiate with its lenders to extend the repayment dates of its indebtedness. There can be no assurance that the Company will be able to successfully restructure its debt obligations in the event it fails to obtain additional financing. These conditions have raised substantial doubt as to the Company’s ability to continue as a going concern for one year from the issuance of the financial statements, which has not been alleviated.

 

5

 

 

Note 3 - Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The Company’s fiscal year end is December 31. The consolidated financial statements include the accounts of American Battery Materials, Inc. and its wholly owned subsidiary, Mountain Sage Minerals, LLC. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and be based on events different from those assumptions. Future events and their effects cannot be predicted with certainty; estimating, therefore, requires the exercise of judgment. Thus, accounting estimates change as new events occur, as more experience is acquired, or as additional information is obtained.

 

Property and Equipment

 

Property and equipment are stated at cost less depreciation. Depreciation is provided using the straight-line method over the estimated useful life of the assets. Equipment has estimated useful lives between three and seven years. Expenditures for ordinary repairs and maintenance are charged to expense as incurred.

 

Impairment of Long-lived Assets

 

Long-lived assets, such as property and equipment, mineral rights and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount to the estimated future undiscounted cash flows expected to be generated by the asset group. If it is determined that an asset group is not recoverable, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value.

 

Mineral Rights and Properties

 

The Company capitalizes acquisition costs until the Company determines the economic viability of the property. Since the Company does not have proven and probable reserves as defined by Securities and Exchange Commission (“SEC”) Regulation S-K Item 1300, exploration expenditures are expensed as incurred. The Company expenses mineral lease costs and repair and maintenance costs as incurred. The Company reviews the carrying value of our properties for impairment, including mineral rights, upon the occurrence of events or changes in circumstances that indicate the related carrying amounts may not be recoverable. During the period ending December 31, 2023, the Company took action to expand on its rights to 102 federal mining claims located in the Lisbon Valley of Utah that it purchased on November 5, 2021, for $100,000, plus the future payment of royalties based on a percentage of the net revenue (2%) from the sale of all minerals produced from this portion of the mining property. The Company acquired and staked additional lithium mining claims adjacent to its Lisbon Valley Project in Utah for $106,000. The new claims have been registered with the Bureau of Land Management. The Company now owns a total of 743 placer claims over 14,320 acres, comprised of (i) the 102 original claims held; and (ii) the 641 new claims. No impairment was recognized, and no additional costs were capitalized, related to the mineral claims during the nine months ended September 30, 2026 and 2025.

 

Earnings Per Share

 

The Company presents basic and diluted earnings per share in accordance with ASC 260, “Earnings per Share.” Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period. Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued. In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive.

 

As of September 30, 2026 and 2025, there were approximately 533,987 and 566,000 shares respectively, potentially issuable under convertible debt agreements, options, warrants and preferred stock that could dilute basic earnings per share if converted that were excluded from the nine months ended September 30, 2026 and 2025 because their inclusion would have been anti-dilutive due to the Company’s net losses.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair market value and then is revalued at each reporting date, with changes in fair value reported in the consolidated statement of operations. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.

 

6

 

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, prepaid expenses and other assets, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities. ASC 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. ASC 820, “Fair Value Measurement,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows:

 

●Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
   
●Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that the Company values using observable market data. Substantially all of these inputs are observable in the marketplace throughout the term of the derivative instruments, can be derived from observable data, or supported by observable levels at which transactions are executed in the marketplace.
   
●Level 3: Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e. supported by little or no market activity). The Company does not have sufficient corroborating evidence to support classifying these assets and liabilities as Level 1 or Level 2.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation,” which requires all stock-based awards granted to employees, directors and non-employees to be measured at grant date fair value of the equity instrument issued and recognized as expense. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award, which is generally equivalent to the vesting period. The fair value of each stock option granted is estimated using the Black-Scholes option pricing model. The measurement date for the non-forfeitable awards to non-employees that vest immediately is the date the award is issued.

 

Revenue Recognition

 

The Company has not generated revenue to date. Revenue, when generated, will be recognized in accordance with ASC 606, “Revenue from Contracts with Customers,” the core principle of which is that an entity should recognize revenue to depict the transfer of control for promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying the revenue recognition principles, an entity is required to identify the contract(s) with a customer, identify the performance obligations, determine the transaction price, allocate the transaction price to the performance obligations and recognize revenue as the performance obligations are satisfied (i.e., either over time or at a point in time). ASC 606 further requires that companies disclose sufficient information to enable readers of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.

 

The Company recognized $0 revenue during the nine months ended September 30, 2026 and 2025.

 

Convertible Debt

 

The Company issues convertible notes as part of its financing strategy, which may contain embedded features such as conversion options, redemption provisions, and contractual adjustments like most favored nations clauses. Convertible debt is accounted for under ASC 470, Debt, as amended by ASU 2020-06, Debt—Debt with Conversion and Other Options. This standard simplifies the accounting by eliminating certain separation models for convertible instruments, requiring the Company to evaluate the debt as a single instrument unless bifurcation of embedded derivatives is required under ASC 815, Derivatives and Hedging.

 

Convertible notes are initially recorded at their principal amount, net of issuance costs or discounts, and classified as liabilities unless specific features mandate equity classification. Interest expense is recognized using the effective interest method over the notes’ terms.

 

The Company’s convertible debt instruments are debt host financial instruments containing embedded features, some of which would otherwise be required to be bifurcated from the debt-host and recognized as separate derivative liabilities subject to initial and subsequent periodic estimated fair value measurements under ASC Topic 815, Derivatives and Hedging. Embedded features are assessed to determine if they require bifurcation as derivatives. Features are bifurcated if their economic characteristics and risks are not clearly and closely related to the debt host, the hybrid instrument is not remeasured at fair value through earnings, and the feature would qualify as a standalone derivative. Bifurcated derivatives are recorded at fair value, with subsequent changes recognized in earnings. However, features contingent on events with low probability (e.g., uplisting or an event of default) are assigned immaterial value. The Company continues to monitor its facts and circumstances in each reporting period to evaluate whether each immaterial embedded feature’s fair value or change to it is significant and would therefore need to be ascribed value.

 

Common stock issued with convertible notes are treated as freestanding equity instruments under ASC 815-40, recorded at fair value in additional paid-in capital, with proceeds allocated between the debt and shares using the relative fair value method. The fair value of the shares issued is treated as a discount to the value of the convertible debt issued.

 

Debt issuance costs are capitalized and amortized as additional interest expense over the debt term, unless allocated to bifurcated derivatives, in which case they are expensed immediately if material.

 

7

 

 

Refinancings of convertible and promissory notes previously issued by the Company are evaluated under ASC 470-50, Modifications and Extinguishments, or ASC 470-60, Troubled Debt Restructurings by Debtors. A refinancing is accounted for as an extinguishment if the present value of cash flows under the new terms differs by at least 10% from the original terms or if a substantive conversion option is added or eliminated. When an extinguishment occurs, the original debt is derecognized and the new debt is recorded at fair value, recognizing any gain or loss in earnings. If not extinguished, a refinancing is treated as a modification with no gain or loss recognition. If the Company were to experience multiple changes to the same debt within a one-year period, and the first of those changes were determined to be a modification, the Company would then evaluate the changes within the one-year period on a cumulative basis.

 

A refinancing is classified as a troubled debt restructuring (TDR) if the Company is experiencing financial difficulty and the creditor grants a concession (e.g., reduced effective interest rate). For TDRs, the carrying amount is adjusted only if undiscounted future cash flows fall below the net carrying value of the original debt. When the undiscounted future cash flows of refinanced debt fall below the net carrying value of the original debt, the Company would record a gain for the difference. It would further adjust the carrying value of the debt to the future undiscounted cash flow amount with no interest expense recorded going forward. All future interest payments would then reduce the carrying value of the respective debt modified. If the undiscounted future cash flows are greater than the carrying value of the original debt, no gain would be recorded. The Company would then calculate a new effective interest rate based upon the carrying value of the original debt and the revised future cash flows under the terms of the new debt.

 

Recent Accounting Pronouncements

 

In November 2024, the FASB issued ASU No. 2024-03, Income Statement (Reporting Comprehensive Income) Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This guidance requires public business entities to disaggregate certain income statement expense captions (such as cost of sales, selling, general and administrative, research and development, etc.) into specified categories in the footnotes. ASU 2025-01 (issued January 2025) clarified the effective dates. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The guidance affects disclosures only; the Company is currently evaluating the impact on its disclosures.

 

In November 2024, the FASB issued ASU No. 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the requirements for determining whether the settlement of a convertible debt instrument should be accounted for as an induced conversion. This guidance is effective for annual periods beginning after December 15, 2025, including interim periods within those annual periods. The Company adopted the guidance prospectively as of January 1, 2026.

 

In January 2025, the FASB issued ASU No. 2025-01, Income Statement (Reporting Comprehensive Income) Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. This ASU solely clarifies the effective date of ASU 2024-03 (see above). The Company does not expect a material impact.

 

In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The amendments clarify and reorganize existing interim reporting guidance, including the scope of Topic 270 and interim disclosure requirements, and introduce a disclosure principle requiring entities to disclose material events or changes occurring since the most recent annual reporting period. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2025-11 on its consolidated financial statements and related disclosures.

 

In December 2025, the FASB issued ASU 2025-12, Accounting Standards Codification Improvements, which clarifies guidance and makes minor improvements across various topics, including earnings per share, receivables, revenue, income taxes, and equity. This ASU is effective for annual periods beginning after December 15, 2026, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements and disclosures.

 

The Company has examined recent accounting pronouncements and determined that they will not have a material impact on its financial position, results of operations, or cash flows.

 

Note 4 – Debt

 

Promissory Notes Payable and Promissory Notes Payable - Related Party

 

During the year ended December 31, 2025:

 

One (1) promissory note agreement was extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $61,376. A total of 3,598 shares of common stock were issued as additional consideration for the 2025 extensions. During the nine months ended September 30, 2026, the note was extended to September 30, 2026, increasing principal to $69,048. A total of 4,016 shares of common stock were issued as additional consideration for the extension. The loss generated by the note extension during 2026 was $7,672, and during 2025 was $15,263. The outstanding principal balance was $69,048 as of September 30, 2026. Accrued interest as of September 30, 2026, was $13,210.

 

8

 

 

The note issued to the related party was extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $976,204. A total of 56,510 shares of common stock were issued as additional consideration for the 2025 extensions. During the quarter ended December 31, 2025, the noteholder sold $145,000 of the value of his promissory note to two noteholders, of which $70,000 was to a related party. The outstanding principal balance was $831,204 as of December 31, 2025. On January 1, 2026, the noteholder assigned $30,000 of the principal of his promissory note to a related party. During the three months ended March 31, 2026, the note was extended to June 30, 2026, increasing the remaining principal of $801,204 to $901,354. A total of 52,748 shares of common stock were issued as additional consideration for the extension. During the nine months ended September 30, 2026, the noteholder sold an aggregate of $527,500 of the principal of his promissory note to three holders not affiliated with the Company, of which $452,500 was reissued as promissory notes and $75,000 was reissued as two convertible notes (see below). On September 4, 2026, the noteholder was issued a new promissory note for the remaining principal balance of $373,854, which was outstanding as of September 30, 2026. Accrued interest as of September 30, 2026, was $161,912. The loss generated by the note extensions during 2026 was $100,150, and during 2025 was $242,767.

 

The promissory note with principal of $139,817, following its 2024 amendment, issued to a holder not affiliated with the Company was extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $186,096. A total of 10,797 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $186,096 as of December 31, 2025. During the nine months ended September 30, 2026, the note was extended to September 30, 2026, increasing principal to $209,358. A total of 12,048 shares of common stock were issued as additional consideration for the extension. Accrued interest as of September 30, 2026, was $37,811. The loss generated by the note extension during 2026 was $23,262, and during 2025 was $46,279.

 

The note issued to the related party was extended to July 31, 2025, and to October 31, 2025, increasing principal to $119,909. On September 30, 2025, the noteholder sold $75,000 of the value of his promissory note to another related party. On October 31, 2025, the note was extended to January 31, 2026, increasing principal to $49,399. A total of 5,651 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $49,399 as of December 31, 2025. During the nine months ended September 30, 2026, the note was extended to September 30, 2026, increasing principal to $55,574. A total of 3,421 shares of common stock were issued as additional consideration for the extension. Accrued interest as of September 30, 2026, was $13,916. The loss generated by the note extension during 2026 was $6,175, and during 2025 was $25,301.

 

The Company entered into 4 promissory note agreements in the aggregate amount of $230,000, of which $155,000 was with related parties. One note was extended to January 31, 2026, increasing principal to $82,500. A total of 1,816 shares of common stock were issued as additional consideration for the extension. All notes were due on January 31, 2026. The outstanding principal balance was $237,500 as of December 31, 2025. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $267,188. A total of 13,981 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $23,922. The loss generated by the note extensions during 2026 was $29,688, and during 2025 was $7,500.

 

During the nine months ended September 30, 2026, the Company entered into 10 promissory note agreements in the aggregate amount of $1,126,354, of which $448,854 was with related parties. Of the total, $270,000 was received in cash and $856,354 was issued with no cash proceeds (re-issued or deducted from prior notes). The notes bear 10% interest per annum. Eight (8) notes matured on September 30, 2026, one (1) note matures on November 30, 2026 and one (1) note matures on December 31, 2026. Two (2) notes were extended with increase in principal from $80,000 to $90,000. A total of 4,608 shares of common stock were issued as additional consideration for the extensions. The outstanding principal balance was $1,136,354 as of September 30, 2026 (of which $452,604 was with related parties). Accrued interest as of September 30, 2026, was $30,880. The loss generated by the note extensions during 2026 was $10,000.

 

On September 30, 2026, the holder of a $202,500 promissory note sold the note to another holder not affiliated with the Company in a private transaction. The Company did not receive any proceeds from the transaction. The replacement note bears 10% interest per annum and matures on November 30, 2026.

 

Convertible Notes Payable and Convertible Notes Payable – Related Party

 

The original Convertible Notes provided for a maturity of 12-months; 7.5% interest per annum; and no right to prepay during the first 6-months after the date of issuance (the “Issuance Date”). Current terms provide for a 10% interest per annum.

 

The Convertible Notes are convertible into shares of common stock of the Company (the “Conversion Shares”) as follows:

 

(a)The Convertible Notes automatically convert into Conversion Shares upon the shares of the Company’s common stock being listed on a higher exchange due to the (i) pricing and funding of an S-1 registration statement; or, (ii) the closing of a transaction resulting in the uplist (either, a “Triggering Transaction”). The conversion price for the Conversion Shares in an automatic conversion shall be equal to: (1) 75% of the price under the Triggering Transaction if within 120-days of the Issuance Date; (2) 70% of the price under the Triggering Transaction if within 121 to 150-days of the Issuance Date; (3) 65% of the price under the Triggering Transaction if more than 150-days of the Issuance Date.

 

(b)The Purchasers have the right to convert into Conversion Shares, in whole or in part, at any time after 180-days following the Issuance Date. The conversion price for the Conversion Shares in a voluntary conversion shall be equal to 65% of the volume weighted average price for the Company’s common stock during the 20-consecutive trading days preceding the conversion.

 

During the year ended December 31, 2024:

 

Notes with six investors not affiliated with the Company were amended with an increase in principal from $1,950,000 to $3,394,584, an increase in interest rate from 7.5% to 10%, and extended until March 31, 2025. During the year ended December 31, 2025, the notes were extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $4,518,191. A total of 266,052 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $4,518,191 as of December 31, 2025. During the three months ended March 31, 2026, one noteholder sold $525,000 of the principal of its convertible note to another holder not affiliated with the Company. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $4,492,340. A total of 266,298 shares of common stock were issued as additional consideration for the extensions. As of September 30, 2026, total principal and accrued interest on these six notes totaled $4,492,340 and $955,665, respectively. The loss generated by the note extensions during 2026 was $499,149, and during 2025 was $1,123,607.

 

9

 

 

Conditions of the note with one (1) purchaser not affiliated with the Company were amended several times (once under the MFN provision) resulting in an increase in principal from $50,000 to $118,670, an increase in interest rate from 7.5% to 10%, and extended until March 31, 2025. During the year ended December 31, 2025, the note was extended to July 31, 2025, to October 31, 2025, and to January 31, 2026. On October 23, 2024, the Company issued 3,567 shares of common stock in compliance with the MFN terms, and a total of 6,975 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $118,670 as of December 31, 2025. During the nine months ended September 30, 2026, the note was extended to September 30, 2026, increasing principal to $133,503. A total of 7,789 shares of common stock were issued as additional consideration for the extension. Accrued interest as of September 30, 2026, was $25,961. The loss generated by the note extension during 2026 was $14,834, and during 2025 was $29,511.

 

The Company entered into ten convertible promissory note agreements in the aggregate amount of $736,511, of which $447,787 was with related parties. During 2024, conditions of the notes were amended under the MFN provision resulting in an increase in principal to $1,047,321 (of which $631,811 was with related parties) and extended until March 31, 2025. During the year ended December 31, 2025, the notes were extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $1,393,983 (of which $840,940 was with related parties). A total of 81,751 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $1,393,983 as of December 31, 2025. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $1,568,231. A total of 91,295 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $301,410. The loss generated by the note extensions during 2026 was $174,248, and during 2025 was $346,662. Of the principal outstanding as of September 30, 2026, $946,058 was with related parties.

 

During the year ended December 31, 2025:

 

The Company entered into five convertible promissory note agreements in the aggregate amount of $105,000, of which $80,000 was with related parties. During 2025, the notes were extended to July 31, 2025, to October 31, 2025, and to January 31, 2026, increasing principal to $139,755 (of which $106,480 was with related parties). A total of 7,829 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $139,755 as of December 31, 2025. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $157,224 (of which $119,790 was with related parties). A total of 8,710 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $22,482. The loss generated by the note extensions during 2026 was $17,469, and during 2025 was $34,755.

 

The Company entered into seven convertible promissory note agreements in the aggregate amount of $245,000, of which $50,000 was with a related party. On July 31, 2025, the notes were extended to October 31, 2025, and on October 31, 2025, to January 31, 2026, increasing principal to $296,450 (of which $60,500 was with a related party). A total of 12,812 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $296,450 as of December 31, 2025. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $333,506 (of which $68,063 was with a related party). A total of 18,203 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $42,943. The loss generated by the note extensions during 2026 was $37,056, and during 2025 was $51,450.

 

The Company entered into seven short-term convertible promissory note agreements in the aggregate amount of $424,921, of which $299,921 was with related parties. Conditions of five notes were amended under the MFN provision resulting in an increase in principal. On October 31, 2025, the notes were extended to January 31, 2026. Note amendments under the MFN provision and extensions resulted in an increase in principal to $480,143 (of which $331,643 was with related parties). A total of 13,373 shares of common stock were issued as additional consideration for the 2025 extensions. The outstanding principal balance was $480,143 as of December 31, 2025. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026, increasing principal to $540,161 (of which $373,098 was with related parties). A total of 28,550 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $53,389. The loss generated by the note extensions during 2026 was $60,018, and during 2025 was $55,221.

 

During the nine months ended September 30, 2026:

 

On January 1, 2026, one noteholder sold $525,000 of the principal of its convertible note to another holder not affiliated with the Company, which on the same day assigned $152,000 of that principal to four other holders not affiliated with the Company, resulting in five convertible notes (one note of $373,000 and four notes of $38,000 each). The Convertible Notes bear 10% interest per annum and were initially due January 31, 2026. During the nine months ended September 30, 2026, the five notes were extended to September 30, 2026, increasing principal to $590,625. A total of 30,399 shares of common stock were issued as additional consideration for the extensions. Accrued interest as of September 30, 2026, was $44,078. The loss generated by the note extensions during 2026 was $65,625.

 

10

 

 

In June 2026, the related-party holder of the promissory note described above sold $75,000 of the principal of his promissory note to a holder not affiliated with the Company, and the Company issued two convertible notes ($50,000 and $25,000) to the purchaser in exchange. The Convertible Notes bear 10% interest per annum and were initially due June 30, 2026. During the nine months ended September 30, 2026, the notes were extended to September 30, 2026. As of September 30, 2026, total principal and accrued interest on these two notes totaled $75,000 and $2,090, respectively.

 

During the three months ended September 30, 2026, the Company issued three convertible notes to holders not affiliated with the Company in the aggregate principal amount of $325,000 ($100,000 on July 13, 2026, $200,000 on August 28, 2026 and $25,000 on September 24, 2026). The Convertible Notes bear 10% interest per annum and are due between September 30, 2026 and December 31, 2026. As of September 30, 2026, total principal and accrued interest on these three notes totaled $325,000 and $4,069, respectively.

 

On August 25, 2026, the Company entered into amendments to its outstanding promissory notes and convertible notes, pursuant to which the maturity date of the notes was extended to September 30, 2026. Under the amendments, in the event that the Company shall not have consummated an uplist of its common stock to NYSE American on or prior to September 30, 2026, then, effective as of September 30, 2026, the principal amount due under the notes shall be increased 15%, for a total increase of $1,459,217, bringing the total principal to $11,187,330, and the Company shall automatically issue 612,476 shares of common stock to the noteholders. The principal increase and share issuance would occur automatically without any further action by the parties. As of the date of the amendments, the Company was not in default under any of its notes. On October 13, 2026, the maturity date of the notes was further extended to November 30, 2026, with effective date of September 30, 2026, subject to an additional principal increase and share issuance if the uplist condition is not met by that date. See Note 9 – Subsequent Events.

 

Scheduled maturities of debt remaining as of September 30, 2026, for each respective fiscal year end are as follows:

 

      
2026   9,953,113 
Total  $9,953,113 

 

Note 5 - Capital Stock

 

On December 8, 2023 and January 24, 2025, the Company effected reverse stock splits of its common stock at ratios of one-for-300 (the “2023 Reverse Split”) and one-for-five (the “2025 Reverse Split”), respectively. In connection with the 2025 Reverse Split, the number of authorized shares of common stock was reduced from 4,500,000,000 to 100,000,000, with no change to the $0.001 par value or to the 10,000,000 authorized shares of preferred stock. All share and per-share amounts in the condensed consolidated financial statements and related notes reflect both reverse splits.

 

Preferred Stock

 

The Company has authorization for preferred stock, which could be issued with voting, liquidation, dividend and other rights superior to common stock. As of September 30, 2026, and December 31, 2025, there were 10,000,000 shares of preferred stock authorized, and 0 shares issued and outstanding.

 

11

 

 

Common Stock

 

The Company has authorized 100,000,000 shares of common stock, with 3,789,585 and 3,142,371 shares issued and outstanding at September 30, 2026 and December 31, 2025.

 

During the nine months ended September 30, 2026, the Company issued 70,135 shares of common stock for services valued at $379,232, 35,013 shares of common stock upon exercise of options valued at $54,270, and 542,066 shares of common stock for note modification.

 

During the nine months ended September 30, 2025, the Company issued 73,118 shares of common stock for services valued at $595,415 and 265,340 shares of common stock for note modification.

 

Note 6 - Stock Options and Warrants

 

Warrants

 

As of September 30, 2026, the Company had no warrant securities outstanding.

 

Options

 

Stock options are awarded to the Company’s employees, consultants and non-employee members of the board of directors under the Equity Incentive Plan and are generally granted with an exercise price equal to the market price of the Company’s common stock at the date of grant. The aggregate fair value of these stock options granted by the Company during the nine months ended September 30, 2026, was determined to be $5,654 using the Black-Scholes-Merton option-pricing model based on the following assumptions: (i) volatility rate of 31%, (ii) zero expected dividend yield, (iii) risk-free rate of 4.01%, (iv) price of $3.75, and (v) expected life of 10 years. For the nine months ended September 30, 2026, the Company recognized share-based compensation expense of $5,654 related to stock options. A summary of option activity under the Company’s Equity Incentive Plan as of September 30, 2026, and changes during the nine months then ended, is presented below:

 

  

Number of

Options

  

Weighted

Average
Exercise Price

  

Weighted

Average

Remaining

Contractual
Term

 
Balance outstanding at December 31, 2025   566,000   $1.61    2.02 
Granted   3,000    3.75    8.58 
Exercised   (35,013)   1.55    1.19 
Forfeited   -    -    - 
Cancelled or expired   -    -    - 
Balance outstanding at September 30, 2026   533,987   $1.63    1.31 
Exercisable at September 30, 2026   253,987   $1.72    1.45 

 

Equity Incentive Plan

 

On August 13, 2024, the Board of Directors adopted the American Battery Materials Inc. 2024 Incentive Compensation Plan (the “2024 Plan”), reserving 800,000 shares of Common Stock for issuance. Awards may be granted to employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its related companies. On October 15, 2025, following approval by our Board of Directors and by written consent of stockholders holding a majority of our outstanding common stock, we amended our 2024 Incentive Compensation Plan to provide for an automatic share reserve mechanism equal to 17.5% of the Company’s issued and outstanding shares of common stock on a fully diluted basis. Under this provision, the number of shares available for issuance under the 2024 Plan automatically increases upon each issuance of common stock or convertible securities by an amount necessary to maintain the 17.5% reserve (calculated on a fully diluted basis), with no downward adjustment if the Company’s capitalization subsequently decreases. Such options may be designated at the time of grant as either incentive stock options or non-qualified stock options. Stock-based compensation includes expense charges related to all stock-based awards. Such awards include options, warrants and stock grants. Generally, the Company issues stock options that vest over three years and expire in 5 to 10 years. As of September 30, 2026, all outstanding awards have been granted under the 2024 Plan.

 

Restricted Stock Units

 

On May 21, 2026, the Board approved an award of 400,000 restricted stock units to Cobrador Capital Advisors LLC, an entity controlled by the Company’s Chief Executive Officer, in connection with advisory services and the Company’s proposed uplisting. The award has an aggregate grant-date fair value of $2,200,000, based on the closing price of the Company’s common stock of $5.50 on the date of grant. Each unit represents the right to receive one share of common stock upon vesting and settlement. No shares were issued at the date of grant, and the units carry no voting or dividend rights prior to settlement.

 

12

 

 

200,000 units vest in full upon completion of an uplisting transaction in which the Company’s common stock commences trading on a major U.S. national securities exchange. The remaining 200,000 units vest in 18 equal monthly installments commencing June 1, 2026, subject to continued service. All unvested units vest upon a change in control. Vested units are settled in shares within 30 days after the end of the month in which vesting occurs.

 

The uplisting condition is a performance condition that is not considered probable until the transaction occurs. Accordingly, no cost has been recognized for the 200,000 units subject to that condition, and $1,100,000 of unrecognized cost will be recognized upon completion of an uplisting transaction, if any.

 

For the three and nine months ended September 30, 2026, the Company recognized $191,667 and $275,000, respectively, of share-based compensation expense related to the time-vesting portion. As of September 30, 2026, 11,111 units had vested and remained unsettled. Unrecognized cost related to the time-vesting portion was $825,000, expected to be recognized over approximately 1.1 years.

 

On July 29, 2026, the Board approved an amendment changing the commencement date of the monthly vesting schedule applicable to 200,000 units from June 1, 2026 to the date of completion of an uplisting transaction. As a result, all 400,000 units are contingent upon completion of an uplisting transaction. The amendment was accounted for as a modification of the award. Because the original service-based vesting conditions were expected to be satisfied at the modification date, the Company continues to recognize the grant-date fair value of the time-vesting portion over the original requisite service period. The modification did not result in incremental fair value.

 

Note 7 – Earnings Per Share

 

Earnings per share calculations are performed in accordance with ASC 260, ‘Earnings Per Share’. Basic earnings per share is calculated using the weighted average number of common shares issued and outstanding during the period, which were 3,695,605 and 2,699,784 for the nine months ended September 30, 2026 and 2025, respectively. Diluted earnings per share includes the dilutive effect of potential common shares, such as those issuable under convertible debt agreements, stock options, warrants, preferred stock and Restricted Stock Units (RSUs), unless their inclusion is anti-dilutive. Approximately 400,000 RSUs represent potential dilution that is contingent upon the Company successfully uplisting to a major exchange. For the nine months ended September 30, 2026 and 2025, approximately 533,987 and 566,000 potential common shares, respectively, were excluded from the diluted earnings per share calculation due to the Company’s reported net losses, as their inclusion would have reduced the loss per share, rendering them anti-dilutive. The determination of anti-dilution was based on the application of the treasury stock method for options and warrants and the if-converted method for convertible debt and preferred stock, as applicable.

 

Note 8 - Segment Information

 

The Company operates and manages its business as one operating and reportable segment, which is the business of renewable energy focused on the extraction, refinement and distribution of technical minerals in an environmentally responsible manner. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer. The Company’s measure of segment profit or loss is net income. For purposes of evaluating performance and allocating resources, the CODM reviews the financial information and evaluates net income against comparable prior periods and the Company’s forecast.

 

For the nine months ended September 30, 2026, the CODM regularly receives and reviews the Company’s net income, and significant operating expenses categories, which are integral to the measure of operating performance. The significant expense categories include employee compensation, office operations and professional services. These expenses are presented below as they are included in the net income measure used by the CODM:

 

  

Three Months

Ended

September 30,

2026

   

Three Months

Ended

September 30,

2025

   

Nine Months

Ended

September 30,

2026

  

Nine Months

Ended

September 30,

2025

 
General and administrative                          
Wages and related  $ (343,388 )   $ (92,014 )   $(1,183,550)  $(1,080,006)
Office operations    (152,433 )     (151,873 )    (161,276)   (161,601)
Professional services    (147,512 )     (48,650 )    (386,214)   (263,645)
Other operating expenses    (3,916 )     (603 )    (14,110)   (3,942)
Total operating expenses    (647,249 )    

(293,140

)    (1,745,150)   (1,509,194)
Other Expenses / Income                          
Gain (loss) on extinguishment of debt    -       (424,656 )    (1,045,346)   (990,109)
Fair value of stock issued for note modification    -      

(863,651

)    (2,572,517)   (1,273,659)
Interest expense    (253,879 )     (184,241 )    (729,157)   (510,810)
Total other expenses / income    (253,879 )     (1,472,548 )    (4,347,020)   (2,774,578)
Net Income (Loss)  $ (901,128 )   $ (1,765,688 )   $(6,092,170)  $(4,283,772)

 

Note 9 - Subsequent Events

 

The Company has evaluated subsequent events through the date the condensed consolidated financial statements were issued. Except as disclosed below, no subsequent events were identified that require recognition or disclosure in the condensed consolidated financial statements.

 

●On October 13, 2026, the Company entered into amendments to its outstanding promissory notes and convertible notes, as reported in its Current Report on Form 8-K filed with the SEC on October 13, 2026. Pursuant to the amendments, the maturity date of the notes was extended from September 30, 2026 to November 30, 2026. If the Company has not consummated an uplist of its common stock to NYSE American on or prior to November 30, 2026, then, effective as of November 30, 2026, the principal amount due under the notes will automatically increase by 15% of the principal balances outstanding as of June 30, 2026, or $1,489,217, and the Company will automatically issue an aggregate of 779,901 shares of common stock to the noteholders, which includes the 612,476 shares issuable under the August 25, 2026 amendments. The principal increase and share issuance would occur automatically without any further action by the parties. The shares would be issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506(b) of Regulation D. The Company is evaluating the accounting for the amendments under ASC 470-50, Debt—Modifications and Extinguishments.
   
●On October 20, 2026, the Company issued 60,000 shares of common stock to a consultant for services provided.

 

13

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis is intended to help you understand our results of operations and financial condition as of September 30, 2026 and for the nine months ended September 30, 2026 and 2025. This discussion and analysis is provided as a supplement to and should be read in conjunction with our condensed consolidated financial statements and the notes to those financial statements that are included elsewhere in this Quarterly Report on Form 10-Q. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Forward-Looking Statements

 

Certain statements contained herein constitute “forward-looking statements”. Except for the historical information contained herein, this Quarterly Report on Form 10-Q contains forward-looking statements (identified by the words “estimate,” “project,” “anticipate,” “plan,” “expect,” “intend,” “believe,” “hope,” “strategy” and similar expressions), which are based on our current expectations and speak only as of the date made. These forward-looking statements are subject to various risks, uncertainties and factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements, including, without limitation, those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 19, 2026 and those described herein that could cause actual results to differ materially from the results anticipated in the forward-looking statements.

 

Factors That May Adversely Affect our Results of Operations

 

Our results of operations may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending and geopolitical instability, such as the military conflict in Ukraine and the Middle East. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude, or the extent to which they may negatively impact our business.

 

Objective

 

The objective of our Management’s Discussion and Analysis of Financial Condition and Results of Operations is to provide users of our financial statements with the following:

 

●a narrative explanation from the perspective of management of our financial condition, results of operations, cash flows, liquidity and certain other factors that may affect future results;

 

●useful context to the financial statements; and

 

●information that allows assessment of the relationship between our past performance and future performance.

 

This Management’s Discussion and Analysis is a supplement to, and should be read together with, our financial statements, including notes, referenced elsewhere in this report, and is provided to enhance your understanding of our operations and financial condition. Due to rounding, some parts of this discussion may not sum or calculate precisely to the totals and percentages provided in the tables.

 

Overview and Outlook

 

We are a U.S. based renewable energy company focused on the extraction, refinement and distribution of technical minerals in an environmentally responsible manner. On November 5, 2021, we acquired the rights to 102 federal mining claims located in the Lisbon Valley of Utah for $100,000 plus the future payment of royalties based on a percentage of the net revenue (2%) from the sale of all minerals produced from this portion of the mining property. The acquisition was driven by historical mineral data from seven existing wells with brine aquifer access. We are defined as an exploration stage issuer, under SEC Regulation S-K Item 1300. An independent third-party technical report indicated that further investment and development in the claims was warranted, although no determination has been made whether we have any reserves of minerals. Similarly, no determination has been made whether mineralization could be economically and legally produced or extracted. We have no mineral reserves as defined by Regulation S-K Item 1300 and have had no mining revenue to date.

 

14

 

 

In July 2023, we acquired and staked additional lithium mining claims adjacent to our Lisbon Valley Project in Utah. The new claims have been registered with the BLM. We now own a total of 743 placer claims over 14,320 acres (approximately 22 square miles), comprised of the 102 original mining claims and 641 new claims.

 

On or about August 28, 2026, we completed the annual maintenance and renewal of our 743 mining claims administered by the United States Department of the Interior, Bureau of Land Management. Through the timely payment of the annual maintenance fees required under federal law and Bureau of Land Management regulations, we maintained the claims in good standing for an additional one-year maintenance period.

 

Our strategy is to employ selective brine extraction technologies that recover targeted minerals and metals from the brine and re-inject the brine into the aquifer, and we continue to evaluate extraction technology providers. We will need funding to support continuing operations and support our growth strategy and we will need to finance operations by offering any combination of equity offerings, debt financing, collaborations, strategic alliances or other licensing arrangements. There is no assurance we will be able to raise sufficient capital to finance our operations.

 

Results of Operations

 

Three months ended September 30, 2026, Compared to Three months ended September 30, 2025.

 

Revenue

 

For the three months ended September 30, 2026, and 2025, our company had no revenue.

 

Operating Expenses

 

General and administrative expenses for the three months ended September 30, 2026, were $647,249, an increase of $354,109 or 121%, compared to $293,140 for the three months ended September 30, 2025. The increase in operating expenses was mainly due to an increase in wages and related expenses, including $191,667 of share-based compensation related to restricted stock units, and professional fees.

 

Gain (Loss) on Extinguishment

 

During the three months ended September 30, 2026 and 2025, our company recorded a loss on extinguishment of debt of $0 and $424,656, respectively.

 

Fair Value of Stock Issued for Note Modification

 

During the three months ended September 30, 2026 and 2025, the Company recorded a fair value of stock issued for note modification of $0 and $863,651, respectively.

 

Interest Expense

 

Interest expense for the three months ended September 30, 2026, was $253,879, as compared to $184,241 during the three months ended September 30, 2025.

 

Net Loss

 

As a result of the foregoing, the net loss for the three months ended September 30, 2026, was $901,128 as compared to the net loss of $1,765,688 during the three months ended September 30, 2025.

 

Nine months ended September 30, 2026, Compared to Nine months ended September 30, 2025.

 

Revenue

 

For the nine months ended September 30, 2026, and 2025, our company had no revenue.

 

Operating Expenses

 

General and administrative expenses for the nine months ended September 30, 2026, were $1,745,150, an increase of $235,956 or 16%, compared to $1,509,194 for the nine months ended September 30, 2025. The increase in operating expenses was mainly due to an increase in professional fees and wages and related expenses.

 

15

 

 

Gain (Loss) on Extinguishment

 

During the nine months ended September 30, 2026 and 2025, our company recorded a loss on extinguishment of debt of $1,045,346 and $990,109, respectively.

 

Fair Value of Stock Issued for Note Modification

 

During the nine months ended September 30, 2026 and 2025, the Company recorded a fair value of stock issued for note modification of $2,572,517 and $1,273,659, respectively.

 

Interest Expense

 

Interest expense for the nine months ended September 30, 2026, was $729,157, as compared to $510,810 during the nine months ended September 30, 2025.

 

Net Loss

 

As a result of the foregoing, the net loss for the nine months ended September 30, 2026, was $6,092,170 as compared to the net loss of $4,283,772 during the nine months ended September 30, 2025.

 

Liquidity and Capital Resources

 

We require cash to fund our operating expenses and working capital requirements, including outlays for capital expenditures. The accompanying consolidated financial statements have been prepared on a going concern basis. Our company had a net loss of $6,092,170 during the nine months ended September 30, 2026, had accumulated losses totaling $37,049,291, and a working capital deficit of $13,307,845 as of September 30, 2026. These conditions raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Since we acquired our first mining claims in November 2021, we have faced an increasingly challenging liquidity situation that has limited our ability to execute our operating plan. Our company will need to raise additional financing in order to fund our operations for the next 12 months and to allow us to continue the development of our business plans and satisfy our obligations on a timely basis. Should additional financing not be available, we will have to negotiate with our lenders to extend the repayment dates of our indebtedness. There can be no assurance that our company will be able to successfully restructure our debt obligations in the event we fail to obtain additional financing.

 

On August 25, 2026, we entered into amendments to our outstanding promissory notes and convertible notes that extended the maturity date of the notes to September 30, 2026. The amendments provided that, if we did not consummate an uplist of our common stock to NYSE American on or prior to September 30, 2026, the principal amount due under the notes would increase 15% ($1,459,217) and we would issue 612,476 shares of common stock to the noteholders. On October 13, 2026, these terms were amended, effective as of September 30, 2026, as described below. See Note 4 - Debt.

 

On October 13, 2026, we further amended the notes to extend their maturity date to November 30, 2026. If we have not consummated an uplist of our common stock to NYSE American on or prior to November 30, 2026, the principal amount due under the notes will automatically increase by 15% of the principal balances outstanding as of June 30, 2026, or $1,489,217, and we will automatically issue an aggregate of 779,901 shares of common stock to the noteholders (inclusive of the 612,476 shares issuable under the August 25, 2026 amendments). See Note 9 - Subsequent Events.

 

Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all and we may not obtain the capital we require by other means. Unless we can attract additional investment, there is substantial doubt about our ability to continue as a going concern.

 

If we are unable to obtain sufficient amounts of additional capital, we may have to cease filing the required reports and cease operations completely. If we obtain additional funds by selling any of our equity securities or by issuing common stock to pay current or future obligations, the percentage ownership of our stockholders will be reduced, stockholders may experience additional dilution, or the equity securities may have rights preferences or privileges senior to the common stock.

 

Cash Flows from Operating Activities

 

During the nine months ended September 30, 2026, our company used $651,285 of cash in operating activities as a result of our net loss of $6,092,170, offset by loss on extinguishment of debt of $1,045,346, fair value of stock issued for note modification of $2,572,517, share-based compensation of $659,886, accrued interest of $717,314, and net changes in operating assets and liabilities of $445,822.

 

During the nine months ended September 30, 2025, our company used $483,456 of cash in operating activities as a result of our net loss of $4,283,772, offset by loss on extinguishment of debt of $990,109, fair value of stock issued for note modification of $1,273,659, share-based compensation of $785,181, accrued interest of $494,766, and net changes in operating assets and liabilities of $256,601.

 

16

 

 

Cash Flows from Investing Activities

 

During the nine months ended September 30, 2026 and 2025, our company had no investing activities.

 

Cash Flows from Financing Activities

 

During the nine months ended September 30, 2026, financing activities provided $649,270, resulting from $325,000 in proceeds from convertible notes, $270,000 in proceeds from promissory notes and $54,270 in proceeds from option exercises.

 

During the nine months ended September 30, 2025, financing activities provided $480,000 in proceeds from convertible notes.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

David E. Graber, who serves as our Chief Executive Officer and Chairman of the Board, Sebastian Lux, who serves as our President and Chief Operating Officer and Agustin Cabo, who serves as our Chief Financial Officer and Principal Financial Officer (collectively referred to herein as “Senior Management”), evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026. The term “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Senior Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on its evaluation, Senior Management concluded as of September 30, 2026 that our disclosure controls and procedures were not effective due to the following material weaknesses in our internal control over financial reporting:

 

●We did not maintain effective controls over the identification and accounting for complex and non-routine transactions. Accordingly, we believe we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual consolidated financial statements would not be prevented or detected on a timely basis.

 

●We do not have controls designed to validate the completeness and accuracy of underlying data used in the determination of accounting transactions. Accordingly, we believe we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual consolidated financial statements would not be prevented or detected on a timely basis.

 

●We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act of 2002 which is applicable to us. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represents a material weakness.

 

●We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represents a material weakness.

 

●We have an inadequate number of personnel with requisite expertise in the key functional areas of finance and accounting.

 

Notwithstanding the identified material weaknesses, Senior Management believes the consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with U.S. GAAP.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. However, Senior Management is currently seeking to improve our controls and procedures in an effort to remediate the deficiencies described above.

 

17

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 19, 2026. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this Quarterly Report on Form 10-Q. As a “smaller reporting company” as defined by Item 10 of Regulation S-K, our company is not required to provide any additional information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The following information represents securities sold by our company during the period covered by this Quarterly Report and the subsequent period, which were not registered under the Securities Act. Included are sales of reacquired securities, as well as new issues, securities issued in exchange for property, services, or other securities, and new securities resulting from the modification of outstanding securities. All issuances were exempt under Section 4(a)(2) of the Securities Act unless otherwise noted.

 

  ● On July 13, 2026, the Company issued a convertible note for the principal amount of $100,000 (in cash). The note bears 10% simple interest and matures December 31, 2026. It converts automatically on an uplist to a national exchange at 65%-75% of the uplist price, depending on timing. Beginning six months after issuance, the holder may convert at 65% of the 20-trading-day VWAP. Conversion is subject to a 4.99% beneficial ownership limit and price-protection adjustments.
  ● On August 28, 2026, the Company issued a convertible note for the principal amount of $200,000 (in cash). The note bears 10% simple interest and matures November 30, 2026. It converts automatically on an uplist to a national exchange at 65%-75% of the uplist price, depending on timing. Beginning six months after issuance, the holder may convert at 65% of the 20-trading-day VWAP. Conversion is subject to a 4.99% beneficial ownership limit and price-protection adjustments.
  ● On September 24, 2026, the Company issued a convertible note for the principal amount of $25,000 (in cash). The note bears 10% simple interest and matures November 30, 2026. It converts automatically on an uplist to a national exchange at 65%-75% of the uplist price, depending on timing. Beginning six months after issuance, the holder may convert at 65% of the 20-trading-day VWAP. Conversion is subject to a 4.99% beneficial ownership limit and price-protection adjustments.
  ● On October 20, 2026, the Company issued 60,000 shares of common stock to a consultant as compensation for services provided.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

During the three months ended September 30, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Item 6. Exhibits

 

Exhibit Number   Exhibit Description
3.1   Certificate of Incorporation, dated March 26, 2007 (incorporated by reference to the Company’s Registration Statement on Form S-1 filed on April 9, 2010).
3.2   Bylaws, as amended (incorporated by reference to the Company’s Registration Statement on Form S-1 filed on April 9, 2010).
3.3   Certificate of Amendment of Certificate of Incorporation, dated October 4, 2010 (incorporated by reference to the Company’s Current Report on Form 8-K filed on October 7, 2010).
3.4   Certificate of Amendment of the Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on March 1, 2018).
3.5   Certificate of Designation for Series A Preferred Shares (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 23, 2022).
3.6   Certificate of Amendment of the Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on October 26, 2022).
3.7   Certificate of Amendment of the Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 8, 2023).
3.8   Certificate of Amendment of the Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on January 24, 2025).
10.1   Form of Note Amendment and Extension Agreement between the Company and investors (incorporated by reference to the Company’s Current Report on Form 8-K filed on April 16, 2024).
31.1*   Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a)
31.2*   Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a)
32.1*   Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350
32.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350
101.INS   Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

November 12, 2026 AMERICAN BATTERY MATERIALS INC.
   
  By: /s/ David E. Graber
    David E. Graber
    Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Agustin Cabo
    Agustin Cabo
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

19

 

Keep reading